Development of CXCR3 antagonists. Part 4: Discovery of 2-amino-(4-tropinyl)quinolines

This publication has 15 references indexed in Scilit:

• Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives
  Bioorganic & Medicinal Chemistry Letters, 2008
• Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists
  Bioorganic & Medicinal Chemistry Letters, 2007
• Identification and structure–activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists
  Bioorganic & Medicinal Chemistry Letters, 2007
• Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
  Trends in Pharmacological Sciences, 2006
• The role of the mast cell in the pathophysiology of asthma
  Journal of Allergy and Clinical Immunology, 2006
• CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
  Current Drug Target - Immune, Endocrine & Metabolic Disorders, 2005
• Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice
  The Journal of Immunology, 2003
• Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients
  Surgery, 2003
• Targeting the Function of IFN-γ-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis
  The Journal of Immunology, 2002
• Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
  Journal of Experimental Medicine, 2000